Ciphergen Biosystems(CIPH): Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ciphergen Biosystems(CIPH):

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (60)	8/19/2002 4:26:18 PM
From: tuck	Read Replies (2) of 510

I was keying on this phrase from the earnings PR this morning . . . >>Accelerating Patent Activities. Ciphergen filed 7 new patent applications in the second quarter, more than in any previous quarter. Many of these applications are directed to multiple biomarkers and assays resulting from work with our research collaborators. Since the beginning of 2002, Ciphergen has filed 12 new patent applications.<< A search at the PTO turned up one patent application related to biomarkers, pertaining to endometrial cancer diagnosis. It was filed by GL Mutter from Harvard, a collaborator and user of PBS', but Ciphergen was not an assignee (#20020106662). There are several involving mitochondria which seem mostly to be produced by MitoKor here in San Diego, apparently a customer, and one that wants to IPO. Then there was a patent application having to do with "concentration" and "no-wash" SELDI, which appear to be improvements that allow for greater sensitivity versus MALDI(#20020060290). Ciphergen is the assignee for this one. Sure would like to find these biomarker patents they're talking of. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next